0001683168-23-007066.txt : 20231011
0001683168-23-007066.hdr.sgml : 20231011
20231011195841
ACCESSION NUMBER: 0001683168-23-007066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231009
FILED AS OF DATE: 20231011
DATE AS OF CHANGE: 20231011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kwietniak Matthew R.
CENTRAL INDEX KEY: 0001974519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 231321556
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2023-10-09
0
0000704562
Avid Bioservices, Inc.
CDMO
0001974519
Kwietniak Matthew R.
14191 MYFORD ROAD
TUSTIN
CA
92780
0
1
0
0
Chief Commercial Officer
0
Common Stock, $0.001 par value
2023-10-09
4
M
0
1261
A
17245
D
Common Stock, $0.001 par value
2023-10-09
4
M
0
1271
A
18516
D
Common Stock, $0.001 par value
2023-10-10
4
S
0
970
9.1996
D
17546
D
Restricted Stock Units
2023-10-09
4
M
0
1261
0.0000
D
Common Stock
1261
40240
D
Restricted Stock Units
2023-10-09
4
M
0
1271
0.0000
D
Common Stock
1271
38969
D
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnotes 4 and 5. This sale does not represent a discretionary trade by the reporting person.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $9.18 to $9.20. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
RSUs granted to the reporting person on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
RSUs granted to the reporting person on July 9, 2023, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2023, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
/s/ Stephen Hedberg, by Power of Attorney for Matthew R. Kwietniak
2023-10-11